Medical Marijuana: The Drug Czar is Wrong (Again)

Washington, D.C.–(ENEWSPF)–November 11, 2009.  In its official response to the AMA’s recent call for a review of marijuana’s status as a Schedule I drug (barring any medical use) under federal law, the White House Office of National Drug Control Policy stated that it would defer to “the FDA’s judgment that the raw marijuana plant cannot meet the standards for identity, strength, quality, purity, packaging and labeling required of medicine.”